9.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Neogenomics Inc Aktie (NEO) Neueste Nachrichten
How hedge fund analytics apply to NeoGenomics Inc. stockMarket Growth Review & Free Technical Pattern Based Buy Signals - newser.com
Measuring NeoGenomics Inc.’s beta against major indicesWeekly Trend Summary & Technical Entry and Exit Tips - newser.com
Visualizing NeoGenomics Inc. stock with heatmapsJuly 2025 Setups & Verified Swing Trading Watchlists - newser.com
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 - PharmiWeb.com
NeoGenomics unveils RaDaR ST at ESMO Congress 2025 - Traders Union
How to track smart money flows in NeoGenomics Inc.Bond Market & Capital Efficient Trading Techniques - newser.com
Published on: 2025-10-13 23:26:51 - newser.com
Is NeoGenomics Inc. stock bottoming outQuarterly Portfolio Summary & Community Consensus Trade Alerts - newser.com
Will NeoGenomics Inc. stock gain from government policiesJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com
How NeoGenomics Inc. stock compares to growth peersJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com
Forecasting NeoGenomics Inc. price range with options dataJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is NeoGenomics Inc. (NG9) stock good for wealth creation2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Volatility clustering patterns for NeoGenomics Inc.July 2025 Levels & Verified Swing Trading Watchlist - newser.com
Is NeoGenomics Inc. stock affected by interest rate hikesJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Published on: 2025-10-13 09:16:58 - newser.com
Regression analysis insights on NeoGenomics Inc. performanceExit Point & AI Driven Stock Movement Reports - newser.com
Earnings visualization tools for NeoGenomics Inc.2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com
NeoGenomics rallies after court win in Natera patent dispute - MSN
NeoGenomics unveils Paletrra revolutionizing spatial proteomics - Traders Union
NeoGenomics' (NEO) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
What catalysts could drive NeoGenomics Inc. stock higher2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Volume spikes in NeoGenomics Inc. stock – what they meanJobs Report & Verified Chart Pattern Signals - newser.com
Is NeoGenomics Inc. forming a bottoming baseEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Is NeoGenomics Inc a good long term investmentMarket Liquidity Analysis & Options Trading Analysis Tools - earlytimes.in
United States Pathological Examination Market Growth & - openPR.com
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - BioSpace
Press Release: NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 - 富途牛牛
NeoGenomics Inc Stock Analysis and ForecastTrading Volume Surges & Outstanding Portfolio Tips - earlytimes.in
What valuation multiples suggest for NeoGenomics Inc. stock2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Piper Sandler Maintains NeoGenomics(NEO.US) With Buy Rating, Maintains Target Price $11 - 富途牛牛
NeoGenomics (NASDAQ:NEO) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
NeoGenomics (NASDAQ:NEO) Trading 9.1% HigherHere's What Happened - MarketBeat
Strategies to average down on NeoGenomics Inc.2025 Earnings Surprises & Daily Entry Point Trade Alerts - newser.com
NeoGenomics (NASDAQ:NEO Shareholders Incur Further Losses as Stock Declines 7.5% This Week, Taking Five-year Losses to 79% - 富途牛牛
Opportunities in the Booming AI in Bioinformatics Market: A $26+ Billion Industry by 2029 Led by Thermo Fisher Scientific, Eurofins Scientific, Dassault Systemes, Illumina and NeoGenomics Laboratories - Yahoo
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):